1. Home
  2. LGVN vs SBFM Comparison

LGVN vs SBFM Comparison

Compare LGVN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • SBFM
  • Stock Information
  • Founded
  • LGVN 2014
  • SBFM 2006
  • Country
  • LGVN United States
  • SBFM Canada
  • Employees
  • LGVN N/A
  • SBFM N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGVN Health Care
  • SBFM Health Care
  • Exchange
  • LGVN Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • LGVN 31.2M
  • SBFM 6.3M
  • IPO Year
  • LGVN 2021
  • SBFM N/A
  • Fundamental
  • Price
  • LGVN $3.05
  • SBFM $0.30
  • Analyst Decision
  • LGVN Strong Buy
  • SBFM Strong Buy
  • Analyst Count
  • LGVN 1
  • SBFM 1
  • Target Price
  • LGVN $12.00
  • SBFM $260.00
  • AVG Volume (30 Days)
  • LGVN 11.3M
  • SBFM 1.2M
  • Earning Date
  • LGVN 08-09-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • LGVN N/A
  • SBFM N/A
  • EPS Growth
  • LGVN N/A
  • SBFM N/A
  • EPS
  • LGVN N/A
  • SBFM N/A
  • Revenue
  • LGVN $978,000.00
  • SBFM $26,739,780.00
  • Revenue This Year
  • LGVN $137.24
  • SBFM $87.97
  • Revenue Next Year
  • LGVN $50.77
  • SBFM $125.23
  • P/E Ratio
  • LGVN N/A
  • SBFM N/A
  • Revenue Growth
  • LGVN N/A
  • SBFM 193.30
  • 52 Week Low
  • LGVN $0.77
  • SBFM $0.28
  • 52 Week High
  • LGVN $35.60
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 54.58
  • SBFM 35.08
  • Support Level
  • LGVN $2.90
  • SBFM $0.29
  • Resistance Level
  • LGVN $3.55
  • SBFM $0.35
  • Average True Range (ATR)
  • LGVN 0.74
  • SBFM 0.03
  • MACD
  • LGVN -0.07
  • SBFM 0.03
  • Stochastic Oscillator
  • LGVN 31.68
  • SBFM 9.25

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: